Market Tracker

12/06 4:44pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

16.00
Delayed Data
As of 4:00pm ET
 +0.40 / +2.56%
Today’s Change
6.91
Today|||52-Week Range
18.00
+71.86%
Year-to-Date
Bristol-Myers Reports Data from Opdivo Combination Studies
10:07am / Zacks.com - Paid Partner Content
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
Dec 05 / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
9:03am / Zacks.com - Paid Partner Content
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data
Dec 05 / Zacks.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
8:51am / Zacks.com - Paid Partner Content
Alexion Presents Data from Ultra-Rare Blood Disorder Study
Dec 05 / Zacks.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Alnylam Reports Positive Data on Fitusiran, Givosiran
Dec 05 / Zacks.com - Paid Partner Content
bluebird Stock Up on Positive Interim Multiple Myeloma Data
Dec 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.60
Today’s open15.60
Day’s range15.35 - 16.10
Volume402,765
Average volume (3 months)784,817
Market cap$685.6M
Dividend yield--
Data as of 4:00pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)+101.11%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.20+3.69%
ITCIIntra-Cellular Thera...+0.93+6.02%
ACIUAC Immune Ltd+0.06+0.50%
ARDXArdelyx Inc+0.80+5.25%
Data as of 4:00pm ET, 12/06/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$0.06
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts